BCAR3 and breast carcinoma: Although not mutually exclusive, a second possibility that may account for the BCAR3-dependent Rac1 activity observed in invasive breast cancer cells is that BCAR3 may actively suppress RhoA signaling, leading indirectly to Rac1 activation (see Fig. 8).